Carbapenem-resistant (CRKP), one of the major nosocomial pathogens, is increasingly becoming a serious threat to global public health. There is an urgent need to develop effective therapeutic and preventive approaches to combat the pathogen. Here, we identified and characterized a novel capsule depolymerase (K64-ORF41) derived from phage SH-KP152410, which showed specific activities for K64-serotype.
View Article and Find Full Text PDFIntroduction: Staphylococcus aureus is a common human pathogen that causes various diseases including infections on the skin, in the bloodstream and the lower respiratory tracts. The emergence of methicillin-resistant S. aureus (MRSA) made the treatment of the bacterial infection more difficult, calling for development of new therapeutics.
View Article and Find Full Text PDFThe increasing prevalence of infections caused by multidrug-resistant necessitates the development of alternative therapies. Here, we isolated, characterized, and sequenced a bacteriophage (SH-KP152226) that specifically infects and lyses capsular type K47. The phage SH-KP152226 contains a genome of 41,420 bp that encodes 48 predicted proteins.
View Article and Find Full Text PDFActa Biochim Biophys Sin (Shanghai)
September 2019
Carbapenem-resistant (CRAB) which is noted as a major pathogen associated with healthcare-associated infections has steadily developed beyond antibiotic control. Lytic bacteriophages with the characteristics of infecting and lysing specific bacteria have been used as a potential alternative to traditional antibiotics to solve multidrug-resistant bacterial infections. Here, we isolated -specific lytic phages and evaluated their potential therapeutic effect against lung infection caused by CRAB clinical strains.
View Article and Find Full Text PDF